"What is there to keep the company solvent?"
No doubt another CR. No problem so the solvency pont is overly dramatic imo.
Could sales be slow to get going over the next 12 months? Sure. The company is still spending on studies for the next product too. However, FDA approval for a product that is an upgrade on an existing product certainly gave me confidence to take one bite. I am still looking for another entry - either on share price weakness likely due to no news flow in the short-term, or a sales number on the upside later this year.
"What is there to keep the company solvent?"No doubt another CR....
-
- There are more pages in this discussion • 2,310 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.005(3.45%) |
Mkt cap ! $34.35M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.0¢ | 14.5¢ | $16.57K | 113.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 125700 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 64039 | 3 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| EYE (ASX) Chart |